Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from COPD

Regeneron: Is It the Perfect Biotech Stock for Value and Growth?

Regeneron is trading at historically low valuations as its Dupixent blockbuster drug could get a 30% increase in TAM if the FDA approves its use in COPD.

MarketBeat

David Lynch death: What are the symptoms and causes of emphysema?

The biggest risk is smoking

The Independent UK

Why Verona Pharma, A Triple-Digit Gainer In 2024, Surged Another 19% This Week

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

UK Using AI To Cut Patient Hospital Visits

The government in the United Kingdom is using artificial intelligence (AI) in the healthcare industry to cut down on hospital visits, having already seen a 40% reduction in the number of COPD patients.

International Business Times

First new treatment for asthma and COPD in half a century – new study

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

The Conversation

New Treatment For Asthma, COPD Flare-Ups: Single Dose Of Existing Antibody Injection May Cut Hospitalizations

A recent trial revealed that a single injection of a monoclonal antibody, benralizumab, could be more effective than standard steroid tablets during asthma or COPD flare-ups.

Medical Daily

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer'

The injection is the first new treatment for asthma and COPD attacks in 50 years

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Benralizumab: London scientists create 'game-changing' first treatment for asthma attacks in 50 years

Researchers say injection will be ‘game changing’ for people with the respiratory condition

Evening Standard

Doctors hail first breakthrough in asthma and COPD treatment in 50 years

Results of trial of benralizumab injection could be ‘gamechanger’ for millions of people around the world

The Guardian - UK

First treatment in 50 years for serious asthma attacks is ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation.

Evening Standard

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’

Benralizumab is a monoclonal antibody that targets specific white blood cells

The Independent UK

Study Finds Daily Dose Of Vitamin B3 Reduces Inflammation In COPD Patients

The study suggests that taking vitamin B3 could reduce lung inflammatory biomarkers by up to 63%.

Medical Daily

What is COPD and what are the symptoms?

Every winter, GP surgeries and hospitals see an increase in visits from people with respiratory conditions.

The Independent UK

AI urine analysis predicts infection in lung disease patients a week in advance

The technology could help personalise treatment and prevent hospitalisations, academics said.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

Dynamite News

Delhi Poor Air Quality records spike Asthma and COPD cases: AIIMS

AIIMS has reported a increase in cases related to respiratory issues, particularly asthma and COPD allegedly due to Delhi air pollution. Read further on Dynamite News:

The Guardian - UK

Pollutionwatch: Study reveals indoor pollution’s impact on people with COPD

Researchers find pollution in inside spaces – mainly from gas cooking – had greatest effect on those with the disease

Medical Daily

Best Nebulizers For Your Respiratory Health: Here's How To Use Them Effectively

Nebulizers are simple devices designed to deliver medications to the lungs directly, making them crucial for treating everything from common colds to more serious conditions like asthma and chronic obstructive pulmonary disease (COPD). In this guide, we explore the various types of nebulizers, their unique benefits, and practical tips for…

Investors Business Daily

Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent

Regeneron stock rose Friday after the company won FDA approval for Dupixent in chronic obstructive pulmonary disease, or COPD.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

What is emphysema? David Lynch reveals he has lung condition

The Twin Peaks creator, 78, says he developed the condition after years of smoking but quit two years ago

Investors Business Daily

Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks

There hasn't been a new COPD treatment in years. But Regeneron stock analysts are closely watching a pair of key FDA decisions.

Investors Business Daily

Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club

Regeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug, Dupixent, in COPD treatment.

The Guardian - UK

Lung disease patients waiting up to 10 years for diagnosis in poorer areas of England

A better testing regime is required as official figures show deaths from chronic obstructive pulmonary disease is three times higher in deprived parts of the country

Zenger

Beetroot Juice Supplements Lower Blood Pressure In COPD Patients

12-week course of daily beetroot juice improves exercise capacity, reduces blood pressure in people with serious lung conditions.

The Hindu

Can’t see elders dying due to poor electricity, say relatives of Kashmir’s COPD patients

Hundreds of Chronic Obstructive Pulmonary Disease patients, dependent on long-term oxygen therapy during winters, are gasping for oxygen in Kashmir due to prolonged and unprecedented electricity cuts

Investors Business Daily

Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales

Regeneron and Sanofi said Monday their blockbuster drug, Dupixent, significantly improved symptoms COPD symptoms.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.